Results 171 to 180 of about 325,686 (199)
SerpinA3 acts as an endogenous TGF‐β receptor antagonist that binds to the extracellular domain of TGFR‐1, thereby preventing TGFR‐1–TGFR‐2 complex formation. This receptor‐level blockade suppresses TGF‐β/Smad2/3 signaling, attenuates cardiac fibroblast activation, and extracellular matrix deposition, and ultimately alleviates pressure overload–induced
Hui Wang +9 more
wiley +1 more source
KAN-GIN: Adaptive Nonlinear Molecular Representation Learning for Drug-Target Affinity Prediction. [PDF]
Bedoui A, Duraisamy N, Cherkaoui M.
europepmc +1 more source
Polypharmacological target-aware molecule generation. [PDF]
Wu K +10 more
europepmc +1 more source
CUE: A Chemical Uncertainty-Aware Embedding Framework for Multimodal Drug Selectivity Prediction. [PDF]
Kim JH, Kim GH, Park HJ, Choi J.
europepmc +1 more source
Antibodies vs. aptamers in cancer diagnosis and therapy: a comparative analysis of clinical applications, mechanisms, and future directions. [PDF]
Beniwal SS +10 more
europepmc +1 more source
From Dual Targeting to Clinical Validation: A Translational Framework for Bispecific Antibody-Drug Conjugates. [PDF]
Kim J, Kang S.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Co-VAE: Drug-Target Binding Affinity Prediction by Co-Regularized Variational Autoencoders
IEEE Transactions on Pattern Analysis and Machine Intelligence, 2022Xing-Ming Zhao, Limin Li, Tianjiao Li
exaly

